Gene therapy startup Rocket Pharma reverse merges with troubled Inotek after $25M raise – Endpoints News
Endpoints News |
Gene therapy startup Rocket Pharma reverse merges with troubled Inotek after $25M raise
Endpoints News Two months after Inotek shares cratered following the second conclusive failure of its lead glaucoma drug — scuttling its share price — the Lexington, MA-based biotech $ITEK has become a reverse merger shell for a gene therapy company called Rocket … Pharma Companies Merge to Advance Gene Therapy Pipeline Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in … |
